Malaria Journal

official impact factor 3.49

Open Access Highly Access

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania

Abdunoor M Kabanywanyi*, Alex Mwita, Deborah Sumari, Renata Mandike, Kefas Mugittu and Salim Abdulla

Malaria Journal 2007, 6:146 doi:10.1186/1475-2875-6-146

Accesses  

  • Last 30 days: 67 accesses
  • Last year: 536 accesses
  • All time: 3867 accesses

Cited by

BioMed Central: 5 citations

Review   Open Access Highly Accessed

The clinical efficacy of artemether/lumefantrine (Coartem®)

Michael Makanga, Srivicha Krudsood Malaria Journal 2009, 8(Suppl 1):S5 (12 October 2009)

Research   Open Access

Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

Maryline Bonnet, Ingrid van den Broek, Michel van Herp, Pedro Urrutia, Chantal van Overmeir, Juliet Kyomuhendo, Célestin Ndosimao, Elizabeth Ashley, Jean-Paul Guthmann Malaria Journal 2009, 8:192 (10 August 2009)

The finding of varying efficacy of the same combinations at two sites in one country highlights one difficulty of implementing a uniform national treatment policy in a large country. The poor efficacy of AS+AQ in Boende should alert the national programme to foci of resistance and emphasizes the need for systems for the prospective monitoring of treatment efficacy at sentinel sites in the country.

Research   Open Access Highly Accessed

A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children

Robin Kobbe, Philipp Klein, Samuel Adjei, Solomon Amemasor, William Thompson, Hanna Heidemann, Maja V Nielsen, Julia Vohwinkel, Benedikt Hogan, Benno Kreuels, Martina Bührlen, Wibke Loag, Daniel Ansong, Jürgen May Malaria Journal 2008, 7:261 (19 December 2008)

Numerous trials have demonstrated high efficacy and safety of artemisinin-based combination therapy (ACT) under supervised treatment but looking how these treatments are applied unsupervised are scarce. Unobserved AL and ASAQ treatment showed high adequate clinical and parasitological responses, though AL was inferior in preventing late clinical failures.

Review   Open Access

The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence

Zulfiqarali G Premji, Salim Abdulla, Bernhards Ogutu, Alice Ndong, Catherine O Falade, Issaka Sagara, Nathan Mulure, Obiyo Nwaiwu, Gilbert Kokwaro Malaria Journal 2008, 7:244 (25 November 2008)

A useful contribution which pulls together data from a number of sources on a question which is constantly raised: whether the African diet is adequate for artemether-lumefantrine absorption.

Research   Open Access Highly Accessed

Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Saharan Africa

Ikeoluwapo O Ajayi, Edmund N Browne, Fred Bateganya, Denis Yar, Christian Happi, Catherine O Falade, Grace O Gbotosho, Bidemi Yusuf, Samuel Boateng, Kefas Mugittu, Simon Cousens, Miriam Nanyunja, Franco Pagnoni Malaria Journal 2008, 7:190 (27 September 2008)

A timely report on an ambitious investigation of parasitological cure rates resulting from use of ACTs within the context of HMM in three African countries. This study helps filling the gaps in evidence needed to guide effective implementation of HMM programmes